Nestle is spending $2 billion to buy a company working to treat peanut allergies - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 51%

United States Headlines News

United States Latest News,United States Headlines

Nestle is spending $2 billion to buy a company working to treat peanut allergies

Thomson ReutersNestle already owns a 25% stake in the company, which is working to develop peanut allergy treatments.

Nestle said on Monday its offer for Aimmune values the California-based drugmaker, in which it already has a stake of around 25.6%, at $2.6 billion.The U.S. company's shares have slumped this year, as the pandemic led to many clinician's offices remaining shut, leading to a slow launch of its therapy, Palforzia, which was approved in January.

"As pandemic-related disruption recedes and Palforzia's true demand begins to manifest, it will be deemed that Nestle got itself a bargain here," Raymond added. The deal helps Nestle, known for its KitKat chocolate bars and Nescafe instant coffee, expand its Nestle Health Science division which it set up in 2011 to open up a new area of business.

Source: News Formal (newsformal.com)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

they'vr already bought Israeli OSEM, for much less...

how about coffee allergy.

2 billion? This is nuts!

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Nestle pays $2 billion to secure Aimmune's allergy treatmentNestle plans to pay $2 billion to gain full ownership of peanut allergy treatment maker Aimmune Therapeutics , as the Swiss company expands its fast-growing health science business. Seeing that Nestle is getting into medical treatment game, does it the mean that Nestle will stop stealing water from Michigan and bottling it for profit? I wouldn't purchase a product made or distributed by Nestle, if they were the only choice available.
Source: Reuters - 🏆 2. / 97 Read more »

Nestlé Moves Further Into Health, Buying Peanut-Allergy Treatment MakerThe Swiss company agreed to buy Aimmune Therapeutics, a biopharmaceutical company that won approval for the first treatment for peanut allergies, in a deal valuing the company at $2.6 billion, including debt. The Democratic Party has become the party of intolerance, censorship and Racism. Democrats have incited riots and promoted Marxist revolution, but offered NO protection to law abiding citizens. The country is waking to their evil and it has sealed their fate! ...just give babies some satay peanut sauce...easy peasy lemon squeazy Trump: 'Make America Hate Again'! REMOVE the most corrupt presidency in US history, the Putin/Trump administration.
Source: WSJ - 🏆 98. / 63 Read more »

Aimmune soars 172% after Nestle agrees to acquire for $2.6 billion - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. Do You Want To create 3d construction logo animation video ? Please Contact Me: LogoAnimation Construction logo animation Character Logo Animation top logo animation
Source: BusinessInsider - 🏆 729. / 51 Read more »

Nestle to buy Aimmune Therapeutics for $2.6 billionNestle said on Thursday it was offering $34.50 per share for the remaining 74.4% in peanut allergy treatment maker Aimmune Therapeutics it does not already own, adding a potential blockbuster to its health science portfolio. About the author of ‘How can we thrive working from home?’ Cherie Diaz is the Managing Director of Australian operations at OpenLearning Limited (ASX:OLL) PwC Australia will on Monday release a report which recommends a tighter partnership between industry and government to address future skills needs with 'micro-credentials'. OpenLearning is leading this Micro Credentials!!
Source: Reuters - 🏆 2. / 97 Read more »

Business Insider's biggest advertising and media stories for August 31 - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. Huge Data Harvesting Great proposition. Would love to see a real Amazon competitor. Whilst I don’t use Tik Tok, there’s no denying it’s monetisation potential.
Source: BusinessInsider - 🏆 729. / 51 Read more »

Emirates airline got $2 billion injection from Dubai government: documentEmirates airline has received 7.3 billion dirhams ($2 billion) from the government of Dubai as it faces a cash crunch caused by the COVID-19 pandemic, a bond prospectus seen by Reuters shows. wow To infect its passengers.beware HHAhmedBinSaeed
Source: Reuters - 🏆 2. / 97 Read more »